Abstract
A food-induced anaphylactic reaction can occur within seconds to a few hours following exposure to the causal food allergen and often affects multiple organ systems including gastrointestinal, cutaneous, respiratory, and cardiovascular. A conundrum in the allergy field is that consumption of the same allergen can cause reactions of vastly different severity in separate individuals; one patient may experience a mild non-life-threatening reaction characterized by pruritis of lips or urticaria whereas another may experience a life-threatening reaction that involves respiratory and cardiovascular compromise leading to loss of consciousness and sometimes death. While there are tests available to determine the predictive risk value of a positive food challenge test or clinical reactivity, there is currently no reliable method to distinguish between individuals who are at risk of mild non-life-threatening versus life-threatening reaction. Recent research has significantly advanced our understanding of the involvement of immune pathways in the effector phase of food-induced anaphylaxis; a void remains regarding our understanding of the contribution of these pathways to severity of disease. In this review, we discuss mild non-life-threatening versus life-threatening food-induced anaphylaxis and factors (co-morbidities and immune activation) that predispose individuals to more severe disease. Furthermore, we summarize recent advancements in our understanding of the involvement of underlying immune pathways in systemic and food-induced anaphylaxis in mouse systems and discuss how these pathways may contribute to more severe disease phenotype.
Similar content being viewed by others
References
Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM (2010) Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol 126:S1–S58
Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, Sigurdardottir ST, Lindner T, Goldhahn K, Dahlstrom J, McBride D, Madsen C (2007) The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol 120:638–646
Sicherer SH (2011) Epidemiology of food allergy. J Allergy Clin Immunol 127:594–602
Branum AM, Lukacs SL (2009) Food allergy among children in the United States. Pediatrics 124:1549–1555
Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA (2010) US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 125:1322–1326
Ben-Shoshan M, Kagan RS, Alizadehfar R, Joseph L, Turnbull E, St Pierre Y, Clarke AE (2009) Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal. J Allergy Clin Immunol 123:783–788
Hourihane JO, Aiken R, Briggs R, Gudgeon LA, Grimshaw KE, DunnGalvin A, Roberts SR (2007) The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J Allergy Clin Immunol 119:1197–1202
Liu AH, Jaramillo R, Sicherer SH, Wood RA, Bock SA, Burks AW, Massing M, Cohn RD, Zeldin DC (2010) National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol 126(798–806):e13
Nicolaou N, Poorafshar M, Murray C, Simpson A, Winell H, Kerry G, Harlin A, Woodcock A, Ahlstedt S, Custovic A (2010) Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 125(191–7):e1–e13
Sampson HA (2003) Anaphylaxis and emergency treatment. Pediatrics 111:1601–1608
Ross MP, Ferguson M, Street D, Klontz K, Schroeder T, Luccioli S (2008) Analysis of food-allergic and anaphylactic events in the national electronic injury surveillance system. J Allergy Clin Immunol 121:166–171
De Smit V, Cameron PA, Rainer TH (2005) Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med 28:381–388
Brown AF, McKinnon D, Chu K (2001) Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 108:861–866
Simons ER, Chad ZH, Gold M (2004) Anaphylaxis in children: realtime reporting from a national network. In: Bienenstock J, Ring J, Togias A (eds) Allergy frontiers and futures: Proceedings of the 24th Symposium of the Collegium Internationale Allergologicum. Hogrefe and Huber Publishers, University of Michigan, 242 pages
Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD (1999) Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 104:452–456
Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, Bellolio MF, Bergstralh EJ, Stead LG, Li JT (2008) The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 122:1161–1165
Liew WK, Williamson E, Tang ML (2009) Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 123:434–442
Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB (2007) Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005. J Allergy Clin Immunol 120:878–884
Australia. ACfAMAi. 2005. Australian Institute of Health and Welfare Asthma Series 2. Canberra (Australia). Australian Institute of Health and Welfare. Catalog no. ACM 6.
Wang J, Sampson HA (2007) Food anaphylaxis. Clin Exp Allergy 37:651–660
Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW (2006) Second symposium on the definition and management of anaphylaxis: summary report–second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 47:373–380
Cianferoni A, Muraro A (2012) Food-induced anaphylaxis. Immunol Allergy Clin North Am 32:165–195
Lieberman P, Nicklas RA, Oppenheimer J, Kemp SF, Lang DM, Bernstein DI, Bernstein JA, Burks AW, Feldweg AM, Fink JN, Greenberger PA, Golden DB, James JM, Ledford DK, Sheffer AL, Blessing-Moore J, Cox L, Khan DA, Lang D, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles S, Wallace D (2010) The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 126(477–80):e1–e42
Sicherer SH (2003) Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics 111:1609–1616
Burks AW, Tang M, Sicherer S, Muraro A, Eigenmann PA, Ebisawa M, Fiocchi A, Chiang W, Beyer K, Wood R, Hourihane J, Jones SM, Lack G, Sampson HA (2012) ICON: food allergy. J Allergy Clin Immunol 129:906–920
Sampson HA (2000) Food anaphylaxis. Br Med Bull 56:925–935
Bock SA, Munoz-Furlong A, Sampson HA (2007) Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol 119:1016–1018
Pumphrey RS, Gowland MH (2007) Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol 119:1018–1019
Pumphrey RS, Roberts IS (2000) Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 53:273–276
Cianferoni A, Novembre E, Mugnaini L, Lombardi E, Bernardini R, Pucci N, Vierucci A (2001) Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985–1996). Ann Allergy Asthma Immunol 87:27–32
Rudders SA, Banerji A, Clark S, Camargo CA Jr (2011) Age-related differences in the clinical presentation of food-induced anaphylaxis. J Pediatr 158:326–328
Novembre E, Cianferoni A, Bernardini R, Mugnaini L, Caffarelli C, Cavagni G, Giovane A, Vierucci A (1998) Anaphylaxis in children: clinical and allergologic features. Pediatrics 101:E8
Fisher MM (1986) Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensiv Care 14:17–21
Brown SG (2005) Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 5:359–364
Brown SG (2007) The pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am 27:165–175
Braganza SC, Acworth JP, McKinnon DR, Peake JE, Brown AF (2006) Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 91:159–163
Brown SG (2004) Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114:371–376
Golden DB, Kwiterovich KA, Kagey-Sobotka A, Lichtenstein LM (1998) Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol 101:298–305
Mueller HL (1959) Further experiences with severe allergic reactions to insect stings. N Engl J Med 261:374–377
Mueller HL (1966) Diagnosis and treatment of insect sensitivity. J Asthma Res 3:331–333
Ring J, Messmer K (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1:466–469
Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS (2009) Work Group report: oral food challenge testing. J Allergy Clin Immunol 123:S365–S383
Schrander JJ, Unsalan-Hooyan RW, Forget PP, Jansen J (1990) [51Cr]EDTA intestinal permeability in children with cow's milk tolerance. J Pediatr Gastroenterol Nutr 10:189–192
Troncone R, Caputo N, Florio G, Finelli E (1994) Increased intestinal sugar permeability after challenge in children with cow's milk allergy or intolerance. Allergy 49:142–146
Van Elburg R, Heymans HS, De MJ (1993) Effect of disodiumcromoglycate on intestinal permeability changes and clinical response during cow's milk challenge. Source (Bibliographic Citation): Pediatr Allergy Immunol 4:79–85
Fau CM, Cardinale F, Fau CF, Martelli A, Fau MA, Muraro A, Fau MA, Pucci N, Fau PN, Savino F, Fau SF, Zappala D, Fau ZD, Panetta V, Panetta V (2011) Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 22:813–819. doi:10.1111/j.399-3038.2011.01200.x
Yunginger JW, Sweeney KG, Sturner WQ, Giannandrea LA, Teigland JD, Bray M, Benson PA, York JA, Biedrzycki L, Squillace DL et al (1988) Fatal food-induced anaphylaxis. JAMA 260:1450–1452
Sampson HA, Mendelson L, Rosen JP (1992) Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 327:380–384
Bock SA, Munoz-Furlong A, Sampson HA (2001) Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 107:191–193
Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30:1144–1150
Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CMM, Tsai M (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749–786
Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD (2002) Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 109:658–668
Dombrowicz D, Flamand V, Brigman KK, Koller BH, Kinet JP (1993) Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell 75:969–976
Lorentz A, Schwengberg S, Mierke C, Manns MP, Bischoff SC (1999) Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 29:1496–1503
Santos J, Benjamin M, Yang PC, Prior T, Perdue MH (2000) Chronic stress impairs rat growth and jejunal epithelial barrier function: role of mast cells. Am J Physiol Gastrointest Liver Physiol 278:G847–G854
Kelefiotis D, Vakirtzi-Lemonias C (1993) In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis. Agents Actions 40:150–156
Strait RT, Morris SC, Smiley K, Urban JF Jr, Finkelman FD (2003) IL-4 exacerbates anaphylaxis. J Immunol 170:3835–3842
Stone SF, Brown SG (2012) Mediators released during human anaphylaxis. Curr Allergy Asthma Rep 12:33–41
Kemp SF, Lockey RF (2002) Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110:341–348
Peavy RD, Metcalfe DD (2008) Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol 8:310–315
Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Muller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF (2007) Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120:S2–S24
Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons KJ, Cass D, Yeung J (2008) Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 358:28–35
Nishio H, Takai S, Miyazaki M, Horiuchi H, Osawa M, Uemura K, Yoshida K, Mukaida M, Ueno Y, Suzuki K (2005) Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med 119:331–334
Walls AF (2000) The roles of neutral proteases in asthma and rhinitis. In: Busse WW, Holgate ST (eds) Asthma and rhinitis. Blackwell, Boston, pp 968–997
Buckley MG, He S, He Y, Goda S, Gelnar J, Walls AF (2006) Carboxypeptidase as a marker of mast cell heterogeneity in human tissues. J Allergy Clin Immunol 117:S85
Zhou XY, Buckley MG, Lau LC, Summers C, Pumphrey RSH, Walls AF (2006) Mast cell carboxypeptidase as a new clinical marker for anaphylaxis. J Allergy Clin Immunol 117:S85
McEuen AR, Buckley MG, Walls AF (2001) The development of diagnostic assays for food-induced anaphylaxis. Food Allergy Intolerance 2:105–121
Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D (1989) Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 83:1551–1555
Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, Tenenbaum C, Westfal RE (2000) Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 106:65–71
Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419–445
Burks AW (2008) Factoring PAF in anaphylaxis. N Engl J Med 358:79–81
Okamoto H, Kamatani N (2008) Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. N Engl J Med 358:1516
Ha TY, Reed ND, Crowle PK (1986) Immune response potential of mast cell-deficient W/Wv mice. Int Arch Allergy Appl Immunol 80:85–94
Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP (1997) Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 99:915–925
Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P (1994) Active anaphylaxis in IgE-deficient mice. Nature 370:367–370
Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ (1997) Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest 99:901–914
Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, Kawano Y, Minegishi Y, Shimizu T, Karasuyama H (2008) Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 28:581–589
Jonsson F, Mancardi DA, Kita Y, Karasuyama H, Iannascoli B, Van Rooijen N, Shimizu T, Daeron M, Bruhns P (2011) Mouse and human neutrophils induce anaphylaxis. J Clin Invest 121:1484–1496
Khodoun MV, Strait R, Armstrong L, Yanase N, Finkelman FD (2011) Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis. Proc Natl Acad Sci U S A 108:12413–12418
Finkelman FD (2007) Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 120:506–515
Finkelman FD, Rothenberg ME, Brandt EB, Morris SC, Strait RT (2005) Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 115:449–457, quiz 58
Berin MC, Mayer L (2009) Immunopathophysiology of experimental food allergy. Mucosal Immunology 2:24–32
Wang J, Sampson HA (2011) Food allergy. J Clin Invest 121:827–835
Li XM, Schofield BH, Huang CK, Kleiner GI, Sampson HA (1999) A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 103:206–214
Li XM, Serebrisky D, Lee SY, Huang CK, Bardina L, Schofield BH, Stanley JS, Burks AW, Bannon GA, Sampson HA (2000) A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 106:150–158
Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, Scribner TA, Zimmermann N, Finkelman FD, Rothenberg ME (2003) Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 112:1666–1677
Birmingham NP, Parvataneni S, Hassan HM, Harkema J, Samineni S, Navuluri L, Kelly CJ, Gangur V (2007) An adjuvant-free mouse model of tree nut allergy using hazelnut as a model tree nut. Int Arch Allergy Immunol 144:203–210
Parvataneni S, Gonipeta B, Tempelman RJ, Gangur V (2009) Development of an adjuvant-free cashew nut allergy mouse model. Int Arch Allergy Immunol 149:299–304
Osterfeld H, Ahrens R, Strait R, Finkelman FD, Renauld JC, Hogan SP (2010) Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J Allergy Clin Immunol 125(469–76):e2
Ahrens R, Osterfeld H, Wu D, Chen C-Y, Groschwitz K, Arumugam M, Strait R, Wang YH, Finkelman FD, Hogan SP (2012) Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice. Am J Pathol 180:1535–1546
Ganeshan K, Neilsen CV, Hadsaitong A, Schleimer RP, Luo X, Bryce PJ (2009) Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model. J Allergy Clin Immunol 123:231–238
Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C, Ahrens R, Seidu L, McKenzie A, Strait R, Finkelman FD, Foster PS, Matthaei KI, Rothenberg ME, Hogan SP (2008) IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 205:897–913
Wills-Karp M (1999) Immunologic basis of antigen-induced airway hyperresponsiveness. Ann Rev Immunol 17:255–281
Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD (1998) Interleukin-13: central mediator of allergic asthma. Science 282:2258–2261
Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261–2263
Gavett SH, O'Hearn DJ, Karp CL, Patel EA, Schofield BH, Finkelman FD, Wills-Karp M (1997) Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol 272:L253–L261
James JM, Eigenmann PA, Eggleston PA, Sampson HA (1996) Airway reactivity changes in asthmatic patients undergoing blinded food challenges. Am J Respir Crit Care Med 153:597–603
James JM, Bernhisel-Broadbent J, Sampson HA (1994) Respiratory reactions provoked by double-blind food challenges in children. Am J Respir Crit Care Med 149:59–64
Strait RT, Morris SC, Finkelman FD (2006) IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest 116:833–841
Kemp SF, Lockey RF (2011) Pathophysiology and organ damage in anaphylaxis. In: Castells MA (ed) Anaphylaxis and hypersensivity reactions. Springer, New York, p 33
Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, Decker WW, Furlong TJ, Galli SJ, Golden DB, Gruchalla RS, Harlor AD Jr, Hepner DL, Howarth M, Kaplan AP, Levy JH, Lewis LM, Lieberman PL, Metcalfe DD, Murphy R, Pollart SM, Pumphrey RS, Rosenwasser LJ, Simons FE, Wood JP, Camargo CA Jr (2005) Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 115:584–591
Silverman HJ, Van Hook C, Haponik EF (1984) Hemodynamic changes in human anaphylaxis. Am J Med 77:341–344
James LP, Austen KF (1964) Fatal systemic anaphylaxis in man. N Engl J Med 270:597–603
Black JH, Kemp HA (1937) Blood density in anaphylaxis in hay fever artificially induced. Am J Clin Pathol 7:300
Sonin L, Grammer LC, Greenberger PA, Patterson R (1983) Idiopathic anaphylaxis. A clinical summary. Annals Intern Med 99:634–635
Munoz J, Bergman RK (1965) Mechanism of anaphylactic death in the mouse. Nature 205:199–200
Bergmann RK, Munoz J (1965) Circulatory chnages in anaphylaxis and histamine toxicity in mice. J Immunol 95:1–8
Fulton JD, Harris WE, Craft CE (1957) Hematocrit chnage as indication of anaphyactic shock in the mouse. Proc Soc Exp Biol Med 95:625–627
Kind LS (1955) Fall in rectal temperature as an indication of anaphylactic shock in the mouse. J Immunol 74:387–390
Brandt EB, Strait RT, Wang Q, Hersko D, Muntel E, Finkelman FD, Rothenberg ME (2003) Oral antigen-induced intestinal anaphylaxis requires IgE-dependent mast cell degranulation. J Allergy Clin Immunol 111:S339
Matsuo H, Morimoto K, Akaki T, Kaneko S, Kusatake K, Kuroda T, Niihara H, Hide M, Morita E (2005) Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 35:461–466
Lambert GP, Broussard LJ, Mason BL, Mauermann WJ, Gisolfi CV (2001) Gastrointestinal permeability during excercise: effects of aspirin and energy-containing beverages. J Appl Physiol 90:2075–2080
Ryan AJ, Chang RT, Gisolfi CV (1996) Gastrointestinal permeability following aspirin intake and prolonged running. Med Sci Sports Exerc 28:698–705
Bengtsson U, Rognum TP, Brandtzaeg P, Kilander A, Hansson G, Ahlstedt S, Hanson LA (1991) IgE-positive duodenal mast cells in patients with food-related diarrhea. Int Arch Allergy Appl Immunol 95:86–91
Caffarelli C, Romanini E, Caruana P, Street ME, dé Angelis G (1998) Clinical food hypersensitivity: the relevance of duodenal immunoglobulin E-positive cells. Pediatr Res 44:485–490
Lillestol K, GHeldeland L, Arslan LG, Florvaag E, Valeur J, Lind R, Berstad A (2010) Indications of atopic bowel in patients with self-reported food hypersensitivity. Aliment Pharmacol Ther 31:1112–1122
Weidner N, Austen KF (1993) Heterogeneity of mast cells at multiple body sites. Path Res Pract 189:156–162
Nolte H, Schiotz PO, Kruse A, Stahl SP (1989) Comparison of intestinal mast cell and basophil histamine release in children with food allergic reactions. Allergy 44:554–565
Akin C, Metcalfe DD (2004) Systemic mastocytosis. Annu Rev Med 55:419–432
Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Gardner JD, Metcalfe DD (1988) Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterol 95:657–667
Soter NA, Austen KF, Wasserman SI (1979) Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301:465–469
Horan RF, Sheffer AL, Austen KF (1990) Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 85:852–855
Brockow K, Jofer C, Behrendt H, Ring J (2008) Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 63:226–232
Gonzalez de Olano D, de la Hoz CB, Nunez Lopez R, Sanchez Munoz L, Cuevas Agustin M, Dieguez MC, Alvarez Twose I, Castells MC, Escribano ML (2007) Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 37:1547–1555
Muller U, Haeberli G (2009) The problem of anaphylaxis and mastocytosis. Curr Allergy Asthma Rep 9:64–70
Groschwitz KR, Ahrens R, Osterfeld H, Gurish MF, Han X, Abrink M, Finkelman FD, Pejler G, Hogan SP (2009) Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci U S A 106:22381–22386
Acknowledgments
The authors would like to thank Drs. Pablo Abonia, Amal Asaad, and Marc Rothenberg for helpful discussions and Shawna Hottinger for editorial assistance. This work was supported in part by NIH R01AI073553-01 (S.P.H), NIH P30DK078392 (R.S), and a VA Merit Award (F.D.F). The authors have no conflicting financial interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of the Special Issue on Food Allergy [34:6]
Rights and permissions
About this article
Cite this article
Hogan, S.P., Wang, Y.H., Strait, R. et al. Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity. Semin Immunopathol 34, 643–653 (2012). https://doi.org/10.1007/s00281-012-0320-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-012-0320-1